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Abstract
Background: Epidemiological documentation of endocrine disruption is complicated by imprecise
exposure assessment, especially when exposures are mixed. Even if the estrogenic activity of all
compounds were known, the combined effect of possible additive and/or inhibiting interaction of
xenoestrogens in a biological sample may be difficult to predict from chemical analysis of single
compounds alone. Thus, analysis of mixtures allows evaluation of combined effects of chemicals
each present at low concentrations.
Methods: We have developed an optimized in vitro E-Screen test to assess the combined functional
e s t r o g e n i c  r e s p o n s e  o f  h u m a n  s e r u m .  T h e  xenoestrogens in serum were separated from
endogenous steroids and pharmaceuticals by solid-phase extraction followed by fractionation by
high-performance liquid chromatography. After dissolution of the isolated fraction in ethanol-
DMSO, the reconstituted extract was added with estrogen-depleted fetal calf serum to MCF-7
cells, the growth of which is stimulated by estrogen. After a 6-day incubation on a microwell plate,
cell proliferation was assessed and compared with the effect of a 17-beta-estradiol standard.
Results and conclusions: To determine the applicability of this approach, we assessed the
estrogenicity of serum samples from 30 pregnant and 60 non-pregnant Danish women thought to
be exposed only to low levels of endocrine disruptors. We also studied 211 serum samples from
pregnant Faroese women, whose marine diet included whale blubber that contain a high
concentration of persistent halogenated pollutants. The estrogenicity of the serum from Danish
controls exceeded the background in 22.7 % of the cases, while the same was true for 68.1 % of
the Faroese samples. The increased estrogenicity response did not correlate with the lipid-based
concentrations of individual suspected endocrine disruptors in the Faroese samples. When added
along with the estradiol standard, an indication of an enhanced estrogenic response was found in
most cases. Thus, the in vitro estrogenicity response offers a promising and feasible approach for an
aggregated exposure assessment for xenoestrogens in serum.
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Background
Epidemiological research on endocrine disruption is
hampered by difficulties in assessment of mixed expo-
sures. A limited number of environmental chemicals have
been characterized with regard to hormonal effects, but
the effect of complex mixtures is virtually unknown. A
promising approach to assess the combined functional
estrogenic response in a serum sample was published by
Sonnenschein, Soto and coworkers in 1995 [1]. This
approach has been further developed and refined by
research groups in the US [2], in Denmark [3] and in
Spain [4].
Although logical and highly attractive, methodological
difficulties must be overcome. Endogenous and pharma-
ceutical estrogens must be removed to avoid interference
with effects caused by environmental chemicals. How-
ever, any pretreatment procedure must at the same time
preserve the environmental chemicals of interest. Due to
similar characteristics of the exogenous compounds that
may bind to the estrogen receptor, this conflict is unlikely
to be resolved in an ideal way. Pretreatment procedures
are limited to physicochemical procedures that will not
necessarily reflect the origin of the compounds and their
physiological properties. Fortunately, many xenoestro-
gens identified so far are generally lipophilic, thus suggest-
ing that a separation based on lipophilicity may constitute
a feasible compromise.
We have refined and modified the original biomarker
method [1] by i) introducing solid-phase extraction (SPE)
of the serum sample with a newly developed SPE-poly-
meric sorbent that exhibits both hydrophilic and
lipophilic retention characteristics [5], thereby ensuring
extraction of a wider range of compounds according to
polarity,  ii) using a modified high-performance liquid
chromatography (HPLC) gradient that covers the mid-
polar area for collection of the early lipophilic fraction
before elution of endogenous estrogens, oral contracep-
tives and metabolites, and iii) applying a modified E-
Screen bioassay [6] that requires smaller amounts of
serum extract and exhibits an increased ability to detect
low-potency estrogenic compounds.
This methodology was applied on a substantial number of
endogenous hormones, oral contraceptives, and a wide
range of environmental pollutants known to be present in
human serum. The information on specific retention
times was used to optimize the HPLC separation proce-
dure to include major xenoestrogens, while excluding
interfering substances.
The biomarker method was used to assess the xenoestro-
genic response of serum samples from 211 pregnant
Faroese women (34th week). This group had a high level
of endogenous estrogens due to pregnancy, and, at the
same time, a complex, mixed dietary exposure to xenoes-
trogens, including PCBs and other persistent halogenated
pollutants that mainly originate from pilot whale blubber
and fish [7,8]. A large number of halogenated organic pol-
lutants are known to occur in biological matrices [9–13],
but the quantitatively dominating environmental pollut-
ants identified in human samples are the major p,p'-DDT
metabolite,  p,p'-DDE, and the PCB congeners
2,2',3,4,4',5'-hexachlorobiphenyl (PCB138), 2,2',4,4',5,
5'-hexachlorobiphenyl (PCB153), and 2,2',3,4,4',5,5'-
heptachlorobiphenyl (PCB180), whereas the hydroxy-
lated metabolites of PCBs are dominated by 4-OH-
2,2',3,4',5,5', 6-heptachlorobiphenyl (4-OH-CB187)
[8,9,12,14].
Methods
Materials
All media ingredients were purchased from In Vitro A/S
(Fredensborg, Denmark) except insulin, sulforhodamine
B (SRB), 2-amino-2-(hydroxymethyl)-1,3-propanediol
(Tris base), trichloroacetic acid (TCA), dimethylsulfoxide
(DMSO) Hybri-Max® (99.7 % purity) that were purchased
from Sigma (St. Louis, MO, US) and gentamicin sulfate
(DuraScan, Odense, Denmark). The charcoal/dextran-
treated fetal calf serum (CT-FCS) batch originated from
the same lot (Lot No. 416632) as the untreated batch
(Biological Industries, Beit Haemek, Israel), and was used
in all experiments. The estrogen antagonist ICI 182,780
(ICI) was kindly provided by Astra Zeneca (Cheshire,
UK). 17-beta-estradiol (E2), o,p'-DDT, p,p'-DDE, estrone,
estriol, 16α-hydroxyestrone, progesterone, cholesterol,
5α-dihydroprogesterone, 17α-hydroxypregnenolone,
androstenedione, dehydroepiandrosterone, 17α-hydrox-
yprogesterone were provided by Sigma (St. Louis, MO,
US). Androsterone and 5α-dihydrotestosterone were
obtained from Steraloids Inc (Newport, RI, US). Testoster-
one and ethanol 96 % were obtained from Fluka (Buchs,
Switzerland). β-HCH was provided by NSI Solutions Inc
(Research Triangle Park, NC, US), methoxychlor, dieldrin,
hexachlorobenzene (HCB), PCB105, PCB118, PCB138,
PCB153, and PCB180 were provided from Dr. Ehrenstor-
fer GmbH (Augsburg, Germany). The hydroxylated PCBs,
4-OH-CB107, 4-OH-CB146 and 4-OH-CB187, were
kindly provided by Dr. Aa. Bergman (Stockholm, Swe-
den). Methanol, n-heptane, ethyl acetate and isopropanol
were of CHROMASOLV®  quality and obtained from
Riedel-de Häen (Seelze, Germany), and 2,2,4-trimethyl-
pentane was from Aldrich (Steinheim, Germany).
Serum samples
A cohort of 547 mother-child pairs was established con-
secutively at the National Hospital in Torshavn, Faroe
Islands, and included women with a wide variation in
exposure to persistent environmental pollutants due toEnvironmental Health: A Global Access Science Source 2003, 2 http://www.ehjournal.net/content/2/1/12
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differences in age and dietary habits. Maternal serum was
collected at the last antenatal hospital visit at the 34th
week of pregnancy. Levels of individual exposures to PCBs
and related compounds were characterized by analyses of
milk collected from the same women 3–5 days after par-
turition; 211 women were then selected to represent the
full range of exposures, with oversampling of subjects
with low and high exposure levels.
As the women in this cohort had the same source of expo-
sure (frequent marine food dinners, including pilot whale
meat and blubber), the ratios between PCB congeners and
related lipophilic pollutants would be expected to vary
only little between the samples. The correlation coeffi-
cients between lipid-based concentrations of PCB105,
PCB118, PCB138, PCB153, PCB156 or PCB180 and o,p'-
DDT, p,p'-DDE, HCB or trans-nonachlor were 0.90–0.95
(as also observed previously [15]), but milk lipid concen-
trations were used in this paper, as the higher fat content
of milk would render these analyses more precise.
The cohort of Danish women consisted of 30 pregnant
(12th – 38th week) and 60 non-pregnant anonymous vol-
unteers. Although we did not have exposure information
for these women, the absence of whale blubber from the
diet and the low-level exposures to persistent organohalo-
gen compounds in Scandinavia suggest that they be con-
sidered controls for comparison with the Faroese cohort.
Serum extraction method
Solid-phase extraction was used to extract xenoestrogens
from serum. Four mL serum was applied to an OASIS HLB
6 cc 500 mg extraction cartridge (Waters, Milford, MA,
US) placed in a Vac Elute SPS 24 Vacuum Manifold (Var-
ian, Harbor City, CA, US). Each cartridge was conditioned
with 3 mL methanol followed by 3 mL Milli-Q water prior
to application of the serum. The serum was allowed to
elute slowly (without applied vacuum) through the car-
tridges and dried with applied vacuum. The extracted
compounds were eluted by 3 mL of methanol followed by
2 mL ethyl acetate into an extraction tube, and evaporated
at 40°C under a gentle nitrogen stream. The remaining
aqueous phase in the extraction tube was further extracted
three times by 1 mL n-heptane/ethyl acetate (1:1, vol/vol)
and centrifuged at 1000 g in 10 min. Following extraction,
the three supernatants were pooled in a new centrifuge
tube, evaporated and reconstituted in 125 µL n-heptane/
ethyl acetate (9:1, vol/vol). An aliquot of 100 µL was
injected into the HPLC system.
Apparatus and chromatographic conditions (HPLC and 
GC)
High performance liquid chromatography separation of
the extracted compounds was performed using a
LaChrom HPLC system consisting of a L-7100 HPLC
pump, a L-7200 Auto Sampler, a L-7400 UV-detector, a L-
7450 Diode-array Detector, a L-7350 Column Thermostat
and a D-7000 Interface Module (Merck, Darmstadt, Ger-
many). Defined fractions of the mobile phase were col-
lected by an L-7650 Fraction Collector (Merck, Darmstadt,
Germany). The system was equipped with a LiChrospher
Silica 60 (5 µm) 250 × 4.6 mm column (Merck, Darm-
stadt, Germany). Elution of the compounds was per-
formed using the gradient system: 0 – 18 min: 90 %
mobile phase A (100 % n-heptane) and 10 % mobile
phase B (methanol/n-heptane/ isopropanol (45:40:15,
vol/vol/vol)); 18 – 22 min: gradient to 50 % A and 50 %
B; 22 – 26 min: gradient to 100 % B; 26 – 28 min: 100 %
B; 28 – 33 min: gradient to 90 % A and 10 % B. 33 – 35
min: 90 % A and 10 % B.
Gas chromatography (GC) was performed on a Hewlett-
Packard 6890 GC equipped with a µ-ECD and a 7683
series injector. Separation was performed on a HP-5MS
capillary column (30 m × 0.25 mm, 0.25 µm film
thickness).
Preparation of samples for E-Screen bioassay
Prior to each analysis the retention time of a standard mix-
ture, including 5α-dihydroprogesterone, testosterone and
estrone, was used to control and adjust time windows for
collection of the HPLC fractions.
The fractions were collected in glass tubes and evaporated
to dryness at 40°C under a gentle nitrogen stream. The
dried sample was reconstituted in 20 µL EtOH/DMSO/
Milli-Q water (50:10:40, vol/vol/vol) by vortexing for 30
sec. Then 200 µL CT-FCS was added and again the content
was mixed by vortexing. The sample was divided in two
aliquots of 100 µL in polypropylene tubes; tube A and B.
To tube A, 900 µL estrogen-free medium was added. From
this solution, aliquots of 200 µL and 100 µL were trans-
ferred to new polypropylene tubes containing 800 µL and
900 µL estrogen-free medium, respectively. To tube B, 900
µL estrogen-free medium supplemented with 10 pM E2
was added, after which aliquots of 200 µL and 100 µL
were transferred to new polypropylene tubes containing
800 µL and 900 µL estrogen-free medium supplemented
with 10 pM E2, respectively. Thus, all serum samples were
analyzed as undiluted samples and as 5- and 10-fold dilu-
tions as well as with and without E2. Prior to the analysis,
it was confirmed that the solvent concentration (0.5 %
ethanol and 0.1 % DMSO) in the final samples did not
affect cell proliferation. Sterile filtering of the samples was
unnecessary and the samples were prepared immediately
prior to use.
Recovery of xenoestrogens after reconstitution
Stock solutions of PCB118, PCB153, o,p'-DDT and p,p'-
DDE, either alone or in mixture, were diluted to a finalEnvironmental Health: A Global Access Science Source 2003, 2 http://www.ehjournal.net/content/2/1/12
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concentration of 50 nM in 13 mL HPLC mobile phase (90
% A and 10 % B) in glass tubes. The sample was divided
in two aliquots of 6.225 mL (equal to the volume of Frac-
tion-1) in glass tubes; tube 1 and 2. Tube 1 was evaporated
to dryness at 40°C under a gentle nitrogen stream. The
dried sample was reconstituted in 20 µL EtOH/DMSO/
Milli-Q water (50:10:40, vol/vol/vol) by vortexing for 30
sec. Then, 200 µL CT-FCS was added and again the con-
tent was mixed by vortexing. Finally, 1.8 mL estrogen-free
medium was added to the vial, after which an aliquot of
2.0 mL was extracted as described for serum samples by
Brock et al, 1996 [16] using a Strata 500 mg trifunctional
C18-e SPE column and a Strata 500 mg Florisil Pesticide
Residue column (Phenomenex, Torrance, CA). The eluted
solvents were collected in a tarred disposable centrifuga-
tion tube and evaporated at 30°C under a gentle nitrogen
stream to about 0.5 mL. After weighing, the remaining
amount was calculated and the volume adjusted to 1000
µL with 2,2,4-trimethylpentane. Tube 2 was evaporated at
40°C under a gentle nitrogen stream to about 0.25 mL.
Again, the remaining amount was calculated, and the vol-
ume adjusted to 1000 µL with 2,2,4-trimethylpentane.
The concentration was determined in an aliquot of 2 µL
by GC analysis.
Microwell E-Screen bioassay
Stock cultures of MCF-7 BUS cells (passage 113–120)
were grown in Dulbecco's modified Eagle's medium
(DMEM) containing 10 % FCS supplemented with 4 mM
glutamine, 15 mM 4-(2-hydroxyethyl)-1-pipera-
zineethanesulfonic acid (HEPES) and 54 µg/L gentamicin
sulfate in an atmosphere of 5 % CO2/95 % air under sat-
urating humidity at 37°C. The microwell E-Screen was
performed as described in Rasmussen and Nielsen, 2002
[6]. Briefly, cells (4500 cells/well) were seeded in 96-well
Nunclon Delta MicroWell plates (Nunc, Roskilde, Den-
mark) and after 24 hr, samples were added in estrogen-
free medium (phenol red-free DMEM containing 10% CT-
FCS supplemented with 4 mM glutamine, 20 mM HEPES,
0.1% sodium bicarbonate and 3 µg/L insulin). In each
experiment, a standard curve for 1 pM – 10 nM E2 was
included. After 6 days, cells were fixed with TCA and
stained with SRB, after which bound dye was solubilized
with 200 µL Tris base. The absorbance at 492 nm was
determined directly in the microwell culture plate using a
microplate reader (Dynatech MRX, Chantilly, VA, US).
Quantitative evaluation
Proliferative effect (PE)
The endpoint of the E-Screen bioassay is the number of
cells after treatment compared to the number of cells in a
negative control sample (cell treated with estrogen-free
medium supplemented with solvent only). Thus, the PE
was calculated as the ratio between the maximum cell pro-
liferation achieved with the test sample and with the neg-
ative control:
Relative proliferative effect (RPE)
For each test sample the RPE was calculated as suggested
by Sonnenschein, Soto and coworkers in 1995 [1] from
the PE of the test sample and the PE of 1 nM E2 in the
same experiment:
Because 1 nM E2 induces maximum response in the E-
Screen bioassay, the RPE describes the ability of the test
sample to induce cell proliferation relative to maximum
E2-induced cell proliferation. Thus, the RPE describes the
efficacy of the test sample relative to that of E2.
However, the PE of 10 pM E2 was used to calculate the
RPE of those experiments where mixture effects were stud-
ied because this concentration induce one-half of the
maximum response. Thus, this RPE describes whether the
test sample has enhancing or inhibiting effects on E2-
induced cell proliferation, e.g., have RPE values above or
below 100 %.
Relative proliferative potency (RPP)
For each individual compound, the RPP was calculated as
suggested by Sonnenschein, Soto and coworkers in 1995
[1] as the ratio between the lowest concentration of E2
that induce maximum response (MOECE2, maximum
observed effect concentration) and the lowest concentra-
tion of test compound that induce maximum response
(MOECtest compound):
Thus, the RPP describes the potency of the test compound
relative to that of E2.
The estrogenic response of a serum sample was regarded
positive when its RPE value was significantly above back-
ground noise, i.e., the variability of negative control val-
ues. For the biomarker assay, the background was defined
as the mean of solvent-treated controls plus three times
the standard deviation.
Statistical analysis
Concentration-response relationships for individual com-
pounds were based on at least three independent
Equation 1 PE
cell number (test sample)
cell number (negati
: =
v ve control)
Equation RPE
PE
PE
test sample
E2
2
1
1
100 :
()
()
=
−
−





 ×
Equation RPP
MOEC
MOEC
E
test compound
3 100 2 : =






×Environmental Health: A Global Access Science Source 2003, 2 http://www.ehjournal.net/content/2/1/12
Page 5 of 14
(page number not for citation purposes)
experiments. Homogeneity of variance between the exper-
iments was tested by Bartlett's test. The data were logarith-
mically transformed if necessary before analysis of
variance (ANOVA). If the ANOVA test showed a signifi-
cant difference (P < 0.05), the Tukey's Multiple Compari-
sons Test was used to identify differences between means.
Associations between the biomarker response determined
in serum and the concentration of environmental pollut-
ants determined in milk were calculated using Pearson
correlation coefficients. The data were logarithmically
transformed before conducting the analysis.
Results
Establishment of HPLC fractions
The advantage of using normal phase chromatography
(NPC), where apolar substances are eluted prior to more
polar substances, is obvious for many reasons. A range of
identified endocrine disrupters are by nature more
lipophilic than the endogenous hormones, and elute
therefore prior to the range of hormones and their metab-
olites in a NPC system. Furthermore, this system utilizes
water free eluents, thereby allowing evaporation of sol-
vents at relative low temperatures and thus minimizing
the risk of a loss of compounds with low vapor pressure.
The use of a gradient system is essential to elute the most
hydrophilic substances prior to the next injection.
Eighty-eight compounds (including alkyl phenols, phtha-
lates, PCBs, organochlorine and carbamate pesticides,
oral contraceptives, and endogenous estrogens) were used
to characterize the HPLC separation (Appendix [see 1]).
The compounds were monitored by diode-array detec-
tion, and a library based on retention time as well as the
UV-spectrum was generated. Calibration curves were pro-
duced for solutions of the compounds at several relevant
concentrations. Recovery studies were performed by com-
paring the peak area obtained from a supplemented
serum sample, extracted and analyzed as described above,
with the peak area obtained from direct injection of an
equivalent amount of the pure standard. The recoveries of
selected compounds relevant for this cohort study are pre-
sented in Table 1. The chromatographic conditions were
developed in order to elute a wide range of xenoestrogens
and other environmental pollutants within the early frac-
tionation period, i.e., before a range of endogenous estro-
gens, oral contraceptives, and metabolites eluted. Based
on the library of specific retention times combined with
information on the estrogenic activity, a HPLC fraction
(Fr-1) was defined that consisted of the initial 5.5 min of
the HPLC eluate. This Fr-1 included the most dominant
parent PCB congeners and some of the hydroxylated PCB
metabolites in biological extracts, but excluded almost all
endogenous estrogens and their metabolites (Table 2).
Table 1: Recovery (%) of supplemented organochlorines from 
CT-FCS after HPLC separation
Compound Recovery
o,p'-DDT 89
p,p'-DDE 85
Methoxychlor 76
PCB52 61
PCB118 55
PCB153 67
PCB180 54
Table 2: Retention time and estrogenic response of indicative compounds
Compound Rt MOEC RPP
µMR P E  ±  S D
Endogenous compounds
Cholesterol 1.83 0.0001–10 Nonactive -
5α-dihydroprogesterone 4.14 10 58 ± 3 0.01
Progesterone 5.03 25 16 ± 2 0.004
Pregnenolone 6.07 10 92 ± 6 0.01
Androsterone 6.21 10 97 ± 3 0.01
5α-dihydrotestosterone 6.63 1 64 ± 5 0.1
Androstenedione 6.80 10 16 ± 2 0.01
Dehydroepiandrosterone 6.86 1 92 ± 2 0.1
Testosterone 8.23 10 34 ± 5 0.01
Estrone 9.06 0.01 84 ± 8 10
17α-hydroxyprogesterone 9.23 10 7 ± 1 0.01
17α-hydroxypregnenolone 12.78 10 30 ± 1 0.01
17β-estradiol 14.83 0.001 100 ± 7 100
16α-hydroxyestrone 22.86 0.01 77 ± 2 10
Estriol 24.01 0.01 103 ± 3 10
Organochlorines
Hexachlorobenzene 1.34 0.001 – 50 Nonactive -Environmental Health: A Global Access Science Source 2003, 2 http://www.ehjournal.net/content/2/1/12
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Recovery of organochlorines after reconstitution
To evaluate our protocol for reconstitution of dried HPLC
fractions in cell culture medium, the recoveries of indica-
tive organochlorines were determined. Stock solutions of
PCB118, PCB153, o,p'-DDT and p,p'-DDE were diluted to
50 nM in HPLC mobile phase. The samples were evapo-
rated to dryness and reconstituted using our protocol
described for reconstitution of serum samples, followed
by determination of the concentration by GC analysis.
The concentration was concomitantly determined in con-
trol samples, and, since the specific recoveries of the inves-
tigated compounds were known (data not shown), we
were able to calculate the recovery of the xenoestrogens in
the reconstituted samples. Specific recoveries in the recon-
stituted samples in cell culture medium are presented in
Table 3. The experiments were repeated with a mixture of
the four compounds, and equivalent percentages were
recovered (Table 3).
Functional estrogenic response of selected environmental 
pollutants
The estrogenicity of major environmental pollutants pre-
viously identified in serum from the cohort of pregnant
Faeroese women was determined. The organochlorine
insecticide, o,p'-DDT had efficacies equivalent to E2, giv-
ing a maximum RPE of 96 ± 7 (Figure 1). The more stable
metabolite of p,p'-DDT, p,p'-DDE, also had a high efficacy,
giving a maximum RPE of 92 ± 2 (Figure 1). The maxi-
mum response to o,p'-DDT was observed upon treatment
with 6.25 µM whereas a concentration of 12.5 µM was
needed to produce an equivalent effect upon treatment
with p,p'-DDE. Thus, o,p'-DDT had a higher potency (RPP
= 0.016) than p,p'-DDE (0.008) (Table 2). When cells
were cotreated with 10 pM E2 (which induce one-half of
the maximum response) and o,p'-DDT or p,p'-DDE, an
enhanced induction of cell proliferation was observed
when compared to that of treatment with 10 pM E2 alone,
indicating additive mixture effects. Another organochlo-
rine insecticide, methoxychlor, had a potency equivalent
to p,p'-DDE, but a significantly lower efficacy (RPE = 57 ±
8) (Table 2 and Figure 1). Methoxychlor also enhanced
the induction of cell proliferation in the presence of E2,
again indicating an additive mixture effect. The organo-
chlorine insecticide dieldrin (RPE = 44 ± 9) had an
efficacy equivalent to methoxychlor, but a lower potency
(0.004) (Table 2 and Figure 1). None of the three major
PCB congeners, PCB138, PCB153 and PCB180, which
constitute about half of the total PCB concentration in
serum from Faroese women [7], induced an estrogenic
response (Figure 1). Also, when tested as a mixture of
equimolar concentrations of the three PCB congeners, no
induction of cell proliferation was detected (Figure 1).
Cotreatment experiments with E2 indicated that each of
these PCB congeners elicits a weak anti-estrogenic effect,
since the proliferative effect of treatment with 10 pM E2
was reduced when compared to that of treatment with 10
pM E2 alone (Figure 1). Cotreatment with a mixture of the
three congeners and E2 resulted in a comparable inhibi-
tion of the E2-induced proliferation (Figure 1). Cytotoxic-
ity tests confirmed that these PCB concentrations were
nontoxic (data not shown). The three most abundant
hydroxylated metabolites of PCB congeners, 4-OH-
CB107, 4-OH-CB146 and 4-OH-CB187, found in serum
from Faroese women, were examined as well. At the high-
est concentration analyzed, 4-OH-CB187 increased cell
PCB180 1.40 0.001 – 50 Nonactive -
p,p'-DDE 1.43 12.5 92 ± 2 0.008
PCB153 1.48 0.001 – 50 Nonactive -
PCB138 1.49 0.001 – 50 Nonactive -
o,p'-DDT 1.53 6.25 96 ± 7 0.016
Dieldrin 1.75 25 44 ± 9 0.004
Methoxychlor 2.29 + 2.88 12.5 57 ± 8 0.008
4-OH-CB146 2.67 0.001 – 50 Nonactive -
4-OH-CB187 2.67 50 24 ± 4 0.002
4-OH-CB107 2.70 0.001 – 50 Nonactive -
β-hexachlorocyclohexane 4.13 2.5 61 ± 2 0.04
Abbreviations: Rt, retention time; MOEC, maximum observed effect concentration; RPE, relative proliferative effect; RPP, relative proliferative 
potency
Table 2: Retention time and estrogenic response of indicative compounds (Continued)
Table 3: Comparison of the recovery (%) of organochlorines (50 
nM each) from reconstituted samples supplemented with a single 
compound or a mixture of four.
Compound Recovery
Single Mixture
o,p'-DDT 54 61
p,p'-DDE 58 66
PCB118 72 67
PCB153 81 80Environmental Health: A Global Access Science Source 2003, 2 http://www.ehjournal.net/content/2/1/12
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E-Screen analysis of environmental pollutants Figure 1
E-Screen analysis of environmental pollutants. MCF-7 cells were treated with the compound indicated in the absence 
(❍ ) or presence () of 10 pM E2. After seven days of culture, cell proliferation was determined using the SRB assay. Results 
are expressed as the relative proliferative effect (RPE) to E2 (y-axis), and concentrations indicated are in µM (x-axis). Values 
shown are mean ± SD from triplicates at two or more independent experiments.
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proliferation reaching a maximum RPE of 24 ± 4 whereas
4-OH-CB107 and 4-OH-CB146 did not induce cell prolif-
eration in the concentration range tested (Figure 1). The
prevalent environmental pollutant HCB, did not induce
cell proliferation, nor affected the proliferative effect of 10
pM E2. In contrast, another environmental pollutant, β-
HCH, induced a marked concentration-dependent induc-
tion of cell proliferation, reaching maximum RPE of 61 ±
2 upon treatment with a concentration of 2.5 µM. As
observed for o,p'-DDT,  p,p'-DDE and methoxychlor, β-
HCH enhanced the proliferative effect in cotreatment
with 10 pM E2, indicating an additive mixture effect.
These results therefore indicate that the parent PCB conge-
ners that constitute the main part of the PCBs present in
serum do not cause an estrogenic effect but rather an anti-
estrogenic effect, though other persistent pollutants usu-
ally occurring along with the PCBs may cause an
estrogenic effect.
Functional estrogenic response of serum from women
Using the biomarker assay the combined functional estro-
genic response of Fr-1 was determined from samples
obtained from non-pregnant female volunteers from the
Danish control group. Most samples did not induce a sig-
nificant induction of cell proliferation (Figure 2, blue
bars). However, a few samples did induce a modest cell
proliferation, thus supporting the notion that this
biomarker assay is very sensitive.
Detailed studies were then performed to examine the
serum estrogenicity of Fr-1 of serum samples from two
pregnant women (35th and 39th week, respectively) from
the Danish control group. Fr-1 from both pregnant
women induced a marked cell proliferation reaching a
maximum RPE of 73 ± 4 and 38 ± 3, respectively (Figure
3). Addition of 1 nM ICI 182,780, a pure anti-estrogen
that completely blocks estrogen receptor (ER)-mediated
responses, completely inhibited cell proliferation induced
by Fr-1 of both samples (Figure 3), thus demonstrating
that the induced cell proliferation was mediated via ER.
Subsequent analyses of subfractions of Fr-1 indicated that
the majority of the serum estrogenicity in both samples
could be ascribed to two minor subfractions – namely s4
(1.8–2.3 min) and s8 (3.8–4.3 min) (Figure 4). The result-
ing effect of the pooled subfractions indicated an additive
mixture effect of the estrogenic substances present in sub-
fraction s4 and s8. Subfractions s4 and s8 were then ana-
lyzed by MS and the endogenous steroid 5α-
dihydroprogesterone was identified in subfraction s8
(data not shown), and subsequent E-Screen analysis indi-
cated that 5α-dihydroprogesterone was a potent
estrogenic compound with a maximum RPE of 58 ± 3
(Table 2). In subfraction s4, the only identifiable com-
pound with a steroid structure was cholesterol, but subse-
quent E-Screen analysis indicated that cholesterol or
cholesterol metabolites potentially formed by the MCF-7
cells during the bioassay did not induce cell proliferation.
However, although fatty acid esters of estrone or estradiol
may be present in serum [17], their potential occurrence
in subfraction s4 could not be documented.
To avoid false positive results, both subfractions s4 and s8
were removed to exclude possible pregnancy-related
estrogens present in serum from pregnant women. The
estrogenic response of the resulting Fr-1 extracts (Figure 2,
purple bars) was not different from that of samples from
non-pregnant women (Figure 2, blue bars) in this cohort,
and the groups were therefore merged into one control
cohort. Of this cohort, 22.7 % of the samples induced cell
proliferation above the background level.
Biomarker analysis of Fraction-1 from unexposed pregnant  women Figure 3
Biomarker analysis of Fraction-1 from unexposed 
pregnant women. Duplicate serum samples from two 
unexposed pregnant women (G1 and G2) from the control 
group were separated on HPLC, followed by E-Screen analy-
sis of the reconstituted Fr-1 (0–5.5 minutes). Fr-1 was ana-
lyzed in the presence or absence of ICI as indicated. Results 
are expressed as the relative proliferative effect (RPE) to E2. 
Values shown are mean ± SD from triplicate wells.
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Functional estrogenic response of serum from PCB-
exposed women
The serum estrogenicity was then determined from sam-
ples obtained from pregnant (34th week) Faroese women.
After HPLC separation, subfractions s4 and s8 were
removed as described above, and all samples were tested
separately by E-Screen analysis as undiluted and as 5- and
10-fold dilutions; below we present the results from the
undiluted samples.
As seen on Figure 5A, 68.1 % of the samples induced cell
proliferation above the background level. Additionally,
enhancing or inhibiting effects of Fr-1 were determined by
co-treatment with 10 pM E2, which would induce one-
half of the maximum response in the E-Screen bioassay. A
few (9.0 %) of the samples inhibited the effect of 10 pM
E2. All of these samples also exhibited reduced estrogenic-
ity as undiluted samples without E2, as compared to 5-
fold dilutions without E2. Most of the remaining samples,
when tested as undiluted samples, enhanced the effect of
10 pM E2 and the results from the unspiked extracts indi-
cated that the mixture effect was additive (Figure 5B).
Correlation between environmental pollutant 
concentration and biomarker response
The concentration of environmental pollutants in breast
milk from the subjects examined had been determined by
GC analyses (Heinzow B. Unpublished data). The
biomarker results were compared with the lipid-based
concentrations of PCBs and related pollutants. However,
except for β-HCH, no statistically significant correlations
were found between serum estrogenicity and any of the
organochlorines analyzed (results not shown). The sam-
ples were then divided into two groups with high and low
total PCB concentration, respectively, and the groups were
compared with the pollutant levels individually. Again,
no association with estrogenic response was observed.
Correlation analyses between the serum antiestrogenic
results and the lipid-based concentrations of PCBs and
related pollutants were also performed but no statistically
significant correlations were found between the biomar-
ker response and any of the organochlorines analyzed.
Discussion
Estrogenicity of environmental pollutants
The estrogenic activities of a range of individual com-
pounds in this study confirm the reported estrogenicity of
Biomarker analysis of Fraction-1 from unexposed women Figure 2
Biomarker analysis of Fraction-1 from unexposed women. Serum samples from unexposed pregnant (n = 30) (purple 
bars) and non-pregnant (n = 60) (blue bars) women were separated on HPLC, followed by E-Screen analysis of the reconsti-
tuted Fr-1 (0–5.5 minutes). For samples from pregnant women, subfractions s4 (1.8–2.3 minutes) and s8 (3.8–4.3 minutes) was 
removed before E-Screen analysis. Results are expressed as the relative proliferative effect (RPE) to E2. Values shown are 
mean ± SD from triplicate wells. The broken line represents the mean background of the experimental series (the mean of 
negative controls + 3x SD).
-20
0
20
40
60
80
100
120
Samples (n =90)
R
P
EEnvironmental Health: A Global Access Science Source 2003, 2 http://www.ehjournal.net/content/2/1/12
Page 10 of 14
(page number not for citation purposes)
the persistent organochlorine insecticides, o,p'-DDT,
methoxychlor and dieldrin [18–22]. The more stable
metabolite of p,p'-DDT, p,p'-DDE, also induced cell prolif-
eration in accordance with previous reports [20,23]. p,p'-
DDE and PCBs constitute the major part of organochlo-
rine residues found in human adipose tissue, milk or
blood [7]. Depending on the position and number of
chlorine substitutions, a range of endocrine disrupting
properties has been reported for different classes of PCB
congeners and their metabolites [24–32]. In the present
study, the major congeners PCB138, PCB153 and PCB180
did not induce an estrogenic response in the E-Screen bio-
assay, but they weakly inhibited E2-induced cell prolifer-
ation when analyzed in combination with E2 indicating
that these compounds might antagonize the activity of
endogenous estrogen. Some of the effects previously
ascribed to parent PCB congeners may rather be caused by
more potent metabolites, e.g., hydroxylated metabolites
[32]. We examined the estrogenicity of the three most
abundant hydroxylated metabolites of PCBs in human
serum, and 4-OH-CB187 was found to be weakly estro-
genic at the highest concentration tested. The environ-
mental pollutant β-HCH was also found to be a potent
xenoestrogen, thus confirming earlier reports [33]. Addi-
tionally, the observed responses when cells were treated
with β-HCH, p,p'-DDE or methoxychlor in combination
with E2, were larger than the response of E2 alone,
thereby indicating that these xenoestrogenic compounds
act together with endogenous estrogen to produce an
enhanced estrogenic effect. Thus, our results indicate that
mixtures of estrogenic compounds seem to cause additive
effects and thus support reports of additive effects of estro-
genic compounds in vitro [34,35]. The data available are,
however, too limited to allow a prediction of the com-
bined estrogenic potential from a conventional chemical
concentration profile of a serum sample.
Establishment of the biomarker assay
The HPLC method was optimized to allow extraction, sep-
aration and collection of mixtures of compounds in
serum samples based on their polarity. The SPE columns
used for the extraction in this study constitute a "univer-
sal" polymeric sorbent that is unique due to its balanced
ratio of two monomers, the lipophilic divinylbenzene,
and the hydrophilic N-vinylpyrrolidone, and allows
extraction of acidic, basic, and neutral compounds in a
wide range of polarities on a single SPE column. Further-
more, this mixed type of sorbent has a larger surface area
and a greater capacity for a wide range of compounds than
do silica-based materials [5].
Biomarker analysis of subfractions of Fraction-1 from pregnant women Figure 4
Biomarker analysis of subfractions of Fraction-1 from pregnant women. Duplicate serum samples from two preg-
nant women (G1 and G2) from the control group were separated on HPLC, and Fr-1 (0–5.5 minutes) was collected in ten sub-
fractions (each 0.5 minutes), indicated as s1 to s10 on the figure. The subfractions from one of the duplicate samples from each 
woman were pooled after HPLC separation, as a positive control of the complete Fr-1. After reconstitution, the samples were 
analyzed by E-Screen. Results are expressed as the relative proliferative effect (RPE) to E2. Values shown are mean ± SD from 
triplicate wells. The broken line represents the background of the experiment (the mean of negative controls + 3x SD). Aster-
isk (*) indicate significant difference (P < 0.05) from background.
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Our HPLC gradient system differs from that proposed by
Sonnenschein, Soto and coworkers [1], because we imple-
ment a relatively long isocratic elution period prior to
applying the gradient. By doing so, the lipophilic
hormone-free elution period is condensed, and the elu-
tion period for midpolar compounds is expanded. This
approach was chosen to increase the ability to separate
compounds in the mid-polar region where endogenous
hormones elute, thus allowing us to eliminate the endog-
enous hormones without loosing too many of the exoge-
nous compounds.
Biomarker analysis of Fraction-1 from PCB-exposed pregnant women Figure 5
Biomarker analysis of Fraction-1 from PCB-exposed pregnant women. Serum samples (n = 211) from the Faroese 
cohort were separated on HPLC, followed by E-Screen analysis of the reconstituted Fr-1 in the absence (A) or presence (B) of 
10 pM E2. Subfractions s4 and s8 was removed before E-Screen analysis. Results are expressed as the relative proliferative 
effect (RPE) to E2. Values shown are mean ± SD from triplicate wells. The broken line represents the background of the exper-
imental series (the mean of negative controls + 3x SD).
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A caveat that needs to be addressed is that the exclusion of
specific fractions, equivalent to a certain range of polari-
ties, will potentially also exclude some exogenous com-
pounds with retention times (polarities) identical to the
endogenous hormones. This is, of course, mainly a prob-
lem when separating unknown mixtures, as individual
retention times of known compounds would otherwise be
available. The wide range of compounds included in this
study with individual retention times demonstrates the
potential of this semi-preparative method. Thus, this
method will allow the user to collect fractions for specific
compounds, mixtures of compounds with known
polarity, or to a total serum sample after exclusion of
endogenous hormones. The HPLC separation may in
principle be followed by a range of different effect moni-
toring assays depending on the compounds separated and
the focus of the research. Our focus in this study was mix-
tures of exogenous compounds potentially acting as
xenoestrogens.
The ability to separate, collect and analyze mixtures of
exogenous compounds instead of individual chemicals is
a significant feature allowing evaluation of combined
effects of chemicals present below their individual no-
observed-effect concentrations. To test estrogenic as well
as anti-estrogenic effects of mixtures of chemicals in
human serum, our improved in vitro E-Screen bioassay [6]
is an effect monitoring system well suited to HPLC-sepa-
rated extracts. Together, the semi-preparative separation
and the E-Screen bioassay act as a biomarker that will
allow us not only to test individual compounds, but also
to address the problems related to environmental or occu-
pational exposure to mixtures of xenoestrogens each
present at low concentrations [35].
We have used this biomarker assay to study the combined
functional estrogenic response in serum from pregnant
women exposed to mixtures of PCBs and other persistent
organochlorines. These compounds are lipophilic to an
extent that allowed us to apply the HPLC-fraction eluting
within the initial 5.5 minutes (after exclusion of two
minor subfractions) for E-Screen analysis. In addition,
this group of women had a high level of endogenous
estrogens due to pregnancy, thus making the elimination
of the endogenous hormones without loosing too many
of the exogenous chemicals a challenging task.
Evaluation of Fraction-1 from PCB-exposed women
The biomarker analysis showed large variations in serum
estrogenicity within the cohort of PCB-exposed Faroese
women and more than two samples out of three induced
a positive estrogenic response. In the presence of E2, an
increased induction of cell proliferation compared to that
of E2 alone was observed in most of these samples, thus
indicating additive mixture effects.
Although it was not a main objective of this study to
search for individually causative chemicals, efforts were
made to assess relationships between the biomarker data
and the concentrations of major environmental pollut-
ants present in milk fat from the same subjects. Except for
β-HCH, we did not find any significant correlations
between the functional estrogenic response and total PCB,
PCB105, PCB118, PCB138, PCB153, PCB156 or PCB180,
or other environmental pollutants such as o,p'-DDT, p,p'-
DDE, HCB, or trans-nonachlor. These chemicals were
analyzed as part of a routine battery of compounds that
were selected for other reasons than endocrine disruption.
However, because concentrations of persistent lipophilic
compounds show collinearity, these pesticide residues
and persistent industrial chemicals are likely to represent
the overall body burden of persistent organohalogen
compounds.
A likely explanation for the lack of significant correlation
between concentrations of these chemicals and our
biomarker results could be that the chemical analysis did
not include the chemicals primarily responsible for the
biomarker effect. In addition, the concentration of the
individual compounds in human serum may be below
the concentration that is needed to elicit effects in our in
vitro cell proliferation assay. The combined response of
the mixture present in serum might, however, be signifi-
cantly enhanced, even when each single compound is
present below its detectable effect limit. Kortenkamp and
coworkers have shown that the combined effect of a mix-
ture of xenoestrogens can produce a significant estrogenic
response even when each individual xenoestrogen is
present at a concentration that alone does not produce a
detectable effect [34,35]. As a result, an explanation in
terms of single causative compounds may not be
expected, because humans are exposed to complex mix-
tures of environmental pollutants. A number of com-
pounds, each present at low, perhaps ineffective
concentrations, may act together to produce effects that
are statistically significant in the biomarker assay. Thus,
the lack of correlation speaks in favor of the biomarker
assay, rather than against, as the method allows detection
of the combined and functional xenoestrogenic response.
Conclusions
This biomarker assay is recommended as an appropriate
and useful tool for assessing the functional estrogenic
potential of complex mixtures present in human serum.
Because of the limited insight into the endocrine disrupt-
ing effects of single chemicals and their mixtures, it may
provide a more accurate prediction of the endocrine dis-
rupting impact than even the most detailed chemical anal-
ysis. Thus, even if the estrogenic activity of all compounds
were known, the combined effect of possible additive
and/or inhibiting interaction of xenoestrogens in aEnvironmental Health: A Global Access Science Source 2003, 2 http://www.ehjournal.net/content/2/1/12
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biological sample may be difficult to predict from chemi-
cal analysis of single compounds alone.
Our finding of an increased average estrogenicity of serum
extracts obtained from an exposed population merits
attention and should inspire further studies into the
causes of this response. Our results do not necessarily
indicate an increased risk of adverse effects, but it should
lead to further efforts to characterize this exposure and its
possible effects. For such studies, this biomarker approach
may serve as a useful supplement to standard exposure
assessment.
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